Q BioMed Inc (QBIO)

[Robertscott]

$QBIO Launched FDA Approved Drug for Non-Opioid Pain Relief
Strontium89 is an FDA approved, non-opioid drug that relieves the severe pain associated with cancer that has
metastasized to bone, a condition that impacts an estimated 10 million people. Strontium89 has been shown to relieve
pain in over 75% of patients who received the treatment. Q BioMed is hopeful that broad market acceptance will be
swift. Strontium89 is reimbursed by Medicare and most private payers, and is anticipated to generate revenues of $25
to $50 million annually in the next 3 years. The drug is now available globally through a Named Patient Program.